ACTIVAS Orthopedics
Tom Afzal, CEO

ACTIVAS Orthopedics is committed to developing complete innovative procedural solutions for the worldwide sports medicine market estimated to be $7.4 billion in 2025. Our product development efforts take into consideration the entire procedure from the initial incision to close of the incision. Our systems provide the surgeon for broad and versatile options to treat their patients.

ACTIVAS Orthopedics’ initial focus is on developing a new “Standard of Care for rotator-cuff surgery. The system provides the surgeon with several options with instrumentation and biologics for either a pre-planned surgery or to meet potential intra-operative changes or requirements. Our goal is to improve patient benefits, optimize surgeon workflow, reduce procedure time, reduce procedural cost and optimize facility efficiency and logistics management with an emphasis on accommodating the shift to the ASC setting.